Thrombectomy System

About Caeli Vascular

Caeli Vascular is an early-stage medical device innovator targeting the significant clinical and economic burden of venous thromboembolic disease, specifically large-volume deep vein thrombosis (DVT). The company has developed a patented, multi-modal technology platform intended to enable physicians to perform more complete and safer clot removal across a wider disease spectrum. Founded by a team of entrepreneurs and surgeons from Washington University in St. Louis, Caeli is positioned to enter a large and underserved market where current endovascular treatment adoption is low due to technological limitations. Its success hinges on clinical validation, regulatory clearance, and commercial execution against established competitors.

Therapeutic Areas